Buscar
Mostrando ítems 11-20 de 49
Doença pulmonar obstrutiva crônica
(2004-12-01)
The chronic obstructive lung disease is reviewed with emphasys on its epidemiology and risk factors. The diagnosis, clinical aspects pulmonary, functional alterations and laboratorial findings are discussed. The treatment ...
The Cost-Effectiveness and Budget Impact of Introducing Indacaterol into the Colombian Health System
(Value in Health Regional, 2012-12)
Objectives
The main objectives were to estimate the cost-effectiveness and budget impact of indacaterol (a once-daily, long-acting-beta2-agonist) compared with 1) salmeterol/fluticasone, 2) formoterol/budesonide, and 3) ...
Estudo da eficácia e tolerabilidade do salmeterol comparativamente ao salbutamol em pacientes com asma brônquica
(Universidade Federal de São Paulo (UNIFESP), 1994)
Future perspectives in COPD
(W B Saunders Co Ltd, 2005-12-01)
The pathophysiology of chronic obstructive pulmonary disease (COPD) is complex. the development of a multidimensional index-such as the BODE index-provides a means of classifying patients with COPD that also correlates ...
Doença pulmonar obstrutiva crônica
(2007-12-01)
Chronic obstructive pulmonary disease (COPD) is considered the forth cause of death in the world. The present review summarizes the epidemiologic and risk factors to the disease. Emphasizing the diagnostic, pulmonary ...
Doença pulmonar obstrutiva crônica
(2001-12-01)
In this review the definition of COPD is presented and the epidemiology and risk factors for disease development are briefly discussed. Characteristics clinical features, pulmonary functions indices, radiologics signs and ...